Last reviewed · How we verify
Prospective, Randomized, Controlled Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine For Pain Management After Abdominoplasty and TRAM Flap Breast Reconstruction.
The purpose of this study is to identify the best pain management for patients undergoing abdominoplasty after massive weight loss or transverse rectus abdominis myocutaneous (TRAM) flap for breast reconstruction. The investigator is conducting this study to compare the effectiveness of a continuous infusion pain pump versus a locally injectable long-acting anesthesia (DepoFoam bupivacaine) versus standard injectable anesthesia (bupivacaine) for post surgical pain control. These drugs and devices are approved by the FDA (Food and Drug Administration) for the purpose of pain control after surgery, and have been used for this purpose before.
Details
| Lead sponsor | Henry Ford Health System |
|---|---|
| Phase | Phase 4 |
| Status | WITHDRAWN |
| Start date | 2014-10 |
| Completion | 2018-12 |
Conditions
- Pain
Interventions
- Exparel
- Marcaine
- Marcaine
Primary outcomes
- Recurrence of Pain — 30 minute to 72 hours after surgery
Countries
United States